EP Patent

EP4600727A2 — Optical filter comprising a variable transmittance layer

Assigned to Solutia Canada Inc · Expires 2025-08-13 · 1y expired

What this patent protects

A optical filter comprising a variable transmittance layer having a first spectrum in a dark state, and a second spectrum in a faded state; and a color balancing layer having a third spectrum; each of the first, second and third spectra comprising a visible portion; the first and…

USPTO Abstract

A optical filter comprising a variable transmittance layer having a first spectrum in a dark state, and a second spectrum in a faded state; and a color balancing layer having a third spectrum; each of the first, second and third spectra comprising a visible portion; the first and third spectra combining to provide a dark state spectrum approximating a dark state target color; and the second and third spectra combining to provide a fades state spectrum approximating a faded state target colour. The optical filter may further comprise a light attenuating layer. The optical filter may further comprise part of a laminated glass.

Drugs covered by this patent

Patent Metadata

Patent number
EP4600727A2
Jurisdiction
EP
Classification
Expires
2025-08-13
Drug substance claim
No
Drug product claim
No
Assignee
Solutia Canada Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.